Current Drugs and Nutraceuticals for the Treatment of Patients with Dyslipidemias.
Sign Up to like & getrecommendations! Published in 2019 at "Current pharmaceutical design"
DOI: 10.2174/1381612825666190130101108
Abstract: Coronary heart disease (CHD) remains the leading cause of disability and death in industrialized Countries. Among many conditions, which contribute to the etiology and progression of CHD, the presence of high low density lipoprotein-cholesterol (LDL-C)… read more here.
Keywords: nutraceuticals treatment; drugs nutraceuticals; patients dyslipidemias; dyslipidemias current ... See more keywords
Current Drugs and Potential Future Neuroprotective Compounds for Parkinson’s Disease
Sign Up to like & getrecommendations! Published in 2019 at "Current Neuropharmacology"
DOI: 10.2174/1570159x17666181127125704
Abstract: The research progress of understanding the etiology and pathogenesis of Parkinson's disease (PD) has yet lead to the development of some clinical approaches intended to treat cognitive and behavioral symptoms, such as memory and per-ception… read more here.
Keywords: bio agents; parkinson disease; potential future; current drugs ... See more keywords